Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A topical multi-ingredient formulation combining **zinc oxide**, **miconazole nitrate**, and **trolamine**. Zinc oxide is a skin protectant and mild astringent; miconazole nitrate is an imidazole antifungal that inhibits ergosterol biosynthesis in fungal cell membranes, particularly effective against Candida species; trolamine acts as an emulsifying and buffering agent. This combination is typically used for adjunctive treatment of diaper dermatitis (diaper rash) when complicated by documented candidiasis (fungal infection) in pediatric patients[1][2][3][4][5]. The cream forms a barrier protecting skin, while the antifungal eliminates fungal overgrowth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zinc oxide + miconazole nitrate + trolamine.